Table 1 Demographic data and clinical characteristics in the derivation cohort among patients with and without D3 SA-AKIÂ SCr
Variable | D3 SA-AKI SCr (n = 140) | No D3 SA-AKI SCr (n = 274) | p value |
|---|---|---|---|
Age (years) | 2.4 (0.9, 6.7) | 4.1 (1.7, 7.7) | 0.003 |
Sex, female (%) | 59 (42.2%) | 131 (47.8%) | 0.274 |
Race (self-identified) | Â | Â | Â |
White/Caucasian | 102 (72.9%) | 203 (74.1%) | 0.947 |
Black/African American | 18 (12.9%) | 35 (12.8%) | Â |
Other | 20 (14.2%) | 36 (13.1%) | Â |
Ethnicity | Â | Â | Â |
Hispanic or Latino | 25 (17.9%) | 43 (15.7%) | 0.485 |
PRISM-III | 15 (9, 21) | 11 (6, 15) |  < 0.001 |
28-day mortality | 28 (20.0%) | 7 (2.6%) |  < 0.001 |
Complicated course | 94 (67.2%) | 55 (20.1%) |  < 0.001 |
PICU LOS | 11 (7, 20) | 7 (3, 12) |  < 0.001 |
PICU free days | 17 (8, 21) | 21 (16, 25) |  < 0.001 |
Day 7 CRRT* | 29/120 (24.2%) | 1/267 (0.01%) |  < 0.001 |